Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01381
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 2, 2019
Authors
Publisher
Frontiers Media SA